Home > Insider Trading > Filing (0001209191-20-025342)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334365	Yuchun Lee	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-20	2,000	$57.27	3,875	No	4	M	Direct
Common Stock	Disposition	2020-04-20	100	$269.97	3,775	No	4	S	Direct
Common Stock	Disposition	2020-04-20	510	$271.52	3,265	No	4	S	Direct
Common Stock	Disposition	2020-04-20	890	$273.61	2,375	No	4	S	Direct
Common Stock	Disposition	2020-04-20	500	$274.65	1,875	No	4	S	Direct
Common Stock	Acquisiton	2020-04-21	2,000	$57.27	3,875	No	4	M	Direct
Common Stock	Disposition	2020-04-21	297	$263.20	3,578	No	4	S	Direct
Common Stock	Disposition	2020-04-21	500	$264.80	3,078	No	4	S	Direct
Common Stock	Disposition	2020-04-21	300	$265.88	2,778	No	4	S	Direct
Common Stock	Disposition	2020-04-21	403	$267.15	2,375	No	4	S	Direct
Common Stock	Disposition	2020-04-21	100	$268.50	2,275	No	4	S	Direct
Common Stock	Disposition	2020-04-21	300	$271.38	1,975	No	4	S	Direct
Common Stock	Disposition	2020-04-21	100	$272.63	1,875	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-04-20	2,000	$0.00	2,000	$57.27
Common Stock	Stock Option (Right to Buy)	Disposition	2020-04-21	2,000	$0.00	2,000	$57.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,125		2022-09-13	No	4	M	Direct
9,125		2022-09-13	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $271.52 (range $271.04 to $271.98).
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $273.61 (range $273.20 to $274.03).
Open market sales reported on this line occurred at a weighted average price of $274.65 (range $274.37 to $275.32).
Open market sales reported on this line occurred at a weighted average price of $263.20 (range $262.68 to $263.65).
Open market sales reported on this line occurred at a weighted average price of $264.80 (range $264.33 to $265.14).
Open market sales reported on this line occurred at a weighted average price of $265.88 (range $265.45 to $266.33).
Open market sales reported on this line occurred at a weighted average price of $267.15 (range $266.85 to $267.47).
Open market sales reported on this line occurred at a weighted average price of $271.38 (range $271.12 to $271.69).
Fully vested.